EarCentric EasyCharge vs MDHearing Volt

The EarCentric EasyCharge is a budget-priced prescription hearing aid available for $229, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear rechargeable device ranks #36 of 39 prescription hearing aids tested, placing it in the bottom tier of its category. In our standardized testing, the EasyCharge demonstrates a stark performance divide. Its standout strength is feedback handling, scoring an excellent 5.0/5—slightly above the category average of 4.72. This means users can expect stable performance without whistling during typical daily activities. However, speech clarity metrics tell a different story: speech in quiet scores just 1.0/5, which is 2.40 points below the category average, and speech in noise also scores 1.0/5, falling 1.11 points below average. Music streaming scored 0.0/5, indicating this device is not suitable for audio enjoyment. Own-voice comfort is also limited at 1.9/5, which is 0.80 points below the prescription hearing aid average of 2.70. The device showed no improvement between initial and tuned fitting conditions, with both scoring 2.7/5. At this price point, shoppers should note that alternatives exist with meaningfully better performance. The RxEars Rxi, available in the same price range, scores 4.07/5. The EasyCharge may appeal to those prioritizing feedback-free operation on a tight budget, but its low speech clarity scores suggest significant limitations for everyday conversation.

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.